Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 83Lung Neoplasms 29Neoplasms 7Neoplasm Metastasis 7Carcinoma 5Colorectal Neoplasms 4NSCLC 3Breast Neoplasms 3Brain Neoplasms 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Non Small Cell Lung Cancer Metastatic 2Multiple Myeloma 2Meningeal Carcinomatosis 2Lymphoma 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Stage II-IIIB Non-small Cell Lung Carcinoma 1Stage IB-IIIA Non-small Cell Lung Carcinoma 1Solid Tumor, Adult 1Solid Tumor 1Small Cell Lung Carcinoma 1

Interventions

pembrolizumab 4Proton Therapy 3toripalimab 1spartalizumab 1patritumab deruxtecan 1osimertinib 1mirdametinib 1leronlimab 1amivantamab 1Valganciclovir 1Radiotherapy 1Paclitaxel 1Lacteol 1Interleukin-2 1Docetaxel 1Carboplatin 1Blood Specimen Collection 1Bevacizumab 1BGB-283 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumor, Adult × osimertinib × 1 year × Clear all
NCT06507306 2026-02-06

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Kumquat Biosciences Inc.

Phase 1 Recruiting
100 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡